Novo Nordisk (NYSE:NVO) 2025 Extraordinary General Meeting Transcript

Novo Nordisk (NYSE:NVO) 2025 Extraordinary General Meeting November 14, 2025 08:00 AM ET Company ParticipantsAnders Ørjan Jensen - Meeting ChairLouise Korpela - PartnerHelge Lund - Chair of the Board of DirectorsLars Rebien Sørensen - ChairHelge LundGood afternoon. On behalf of the board, welcome to Novo Nordisk Extraordinary General Meeting 2025. I am Helge Lund and I'm the Chair of the Board of Directors. Today's meeting is held in English and is a fully virtual meeting. Simultaneous translation to Danish ...